2010
DOI: 10.1021/np100657w
|View full text |Cite
|
Sign up to set email alerts
|

Human Cytochrome P450 Liability Studies of trans-Dihydronarciclasine: A Readily Available, Potent, and Selective Cancer Cell Growth Inhibitor

Abstract: The cytochrome P45O activities of the naturally occurring Amaryllidaceae alkaloid narciclasine (3), isolated from Narcissus pseudonarcissus, and synthetic derivative trans-dihydronarciclasine (5) are reported. While narciclasine was found to possess potent inhibitory activity to human CYP3A4, its dihydro analogue was inactive. This study revealed that the C1-C10b double bond is required for inhibition of this crucial metabolizing enzyme. Compound 5 also demonstrated no inhibition of the related human cytochrom… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
12
0
1

Year Published

2012
2012
2016
2016

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 32 publications
(14 citation statements)
references
References 35 publications
0
12
0
1
Order By: Relevance
“…Anticancer investigations of these analogues demonstrated that 6 constitutes the minimum anticancer pharmacophore in the series 2lp. Additionally, the 1‐10b‐styryl double bond in narciclasine ( 3 ) is associated with unwanted cytochrome P 450 activity,2q thus highlighting the importance of 5 and 6 toward developing a potent and selective anticancer agent.…”
Section: Methodsmentioning
confidence: 99%
“…Anticancer investigations of these analogues demonstrated that 6 constitutes the minimum anticancer pharmacophore in the series 2lp. Additionally, the 1‐10b‐styryl double bond in narciclasine ( 3 ) is associated with unwanted cytochrome P 450 activity,2q thus highlighting the importance of 5 and 6 toward developing a potent and selective anticancer agent.…”
Section: Methodsmentioning
confidence: 99%
“…Natural (+)‐ trans ‐dihydronarciclasine 1 has been the subject of three prior asymmetric syntheses, three racemic syntheses, and the compound has also been the subject of semi‐synthesis via selective hydrogenation of narciclasine 3 . We were inspired by recent enantioselective organocatalytic approaches toward six member carbacycles to develop a stepwise [3+3]‐type Michael‐aldol sequence, involving an α‐nitrogen‐substituted acetone moiety reacting with an unsaturated aldehyde, as a rapid entry to the amaryllidaceae core.…”
Section: Figurementioning
confidence: 99%
“…The infamous azaspiracid poisoning incident happened in 1995 when at least eight people in the Netherlands fell ill after consuming blue mussels (Mytilus edulis). [23] In 1998, the Yasumoto group isolated the causative toxin for this poisoning as azaspiracid-1 (33). [24] Since then, 11 azaspiracid analogues have been described.…”
Section: Asymmetric Hetero-diels-alder Reactions In the Total Synthesmentioning
confidence: 99%
“…An interesting application of an enantioselective nitroso-Diels-Alder reaction was reported in the total synthesis of trans-dihydronarciclasine (45; Scheme 7). [33] The desired stereochemistry in the target molecule was induced by the key HDA reaction between a decorated cyclohexadiene (39) and 2-nitrosopyridine (40), thus yielding the regioisomeric bicyclic compounds 42 and 43 with ee values of up to 99 %. [34] The HDA reaction was catalyzed with the chiral Walphos catalyst 41 in the presence of copper(I).…”
Section: Asymmetric Hetero-diels-alder Reactions In the Total Synthesmentioning
confidence: 99%